Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP493299.RAB9u0cK4stgW8TsX61_s9OJnP6B-Lm5WHDeh4VHPebyE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP493299.RAB9u0cK4stgW8TsX61_s9OJnP6B-Lm5WHDeh4VHPebyE130_assertion type Assertion NP493299.RAB9u0cK4stgW8TsX61_s9OJnP6B-Lm5WHDeh4VHPebyE130_head.
- NP493299.RAB9u0cK4stgW8TsX61_s9OJnP6B-Lm5WHDeh4VHPebyE130_assertion description "[These mutations can affect the pre-S2/S promoter controlling HBV envelope protein expression (hepatitis B surface antigen (HBsAg)) and have been associated with worsened clinical outcome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP493299.RAB9u0cK4stgW8TsX61_s9OJnP6B-Lm5WHDeh4VHPebyE130_provenance.
- NP493299.RAB9u0cK4stgW8TsX61_s9OJnP6B-Lm5WHDeh4VHPebyE130_assertion evidence source_evidence_literature NP493299.RAB9u0cK4stgW8TsX61_s9OJnP6B-Lm5WHDeh4VHPebyE130_provenance.
- NP493299.RAB9u0cK4stgW8TsX61_s9OJnP6B-Lm5WHDeh4VHPebyE130_assertion SIO_000772 15871998 NP493299.RAB9u0cK4stgW8TsX61_s9OJnP6B-Lm5WHDeh4VHPebyE130_provenance.
- NP493299.RAB9u0cK4stgW8TsX61_s9OJnP6B-Lm5WHDeh4VHPebyE130_assertion wasDerivedFrom befree-2016 NP493299.RAB9u0cK4stgW8TsX61_s9OJnP6B-Lm5WHDeh4VHPebyE130_provenance.
- NP493299.RAB9u0cK4stgW8TsX61_s9OJnP6B-Lm5WHDeh4VHPebyE130_assertion wasGeneratedBy ECO_0000203 NP493299.RAB9u0cK4stgW8TsX61_s9OJnP6B-Lm5WHDeh4VHPebyE130_provenance.